Related Funds
Funds with similar focus
Fund Name | Location |
Adani Capital | Central, Central Region, Singapore |
Antenna Group | California, San Francisco, United States |
Beecken Petty O'Keefe & Company | Chicago, Illinois, United States |
Chaosheng Capital | - |
Chemdex | California, Carlsbad, United States |
Cobin Angels | Mazowieckie, Poland, Warsaw |
Comcast Interactive Media | Pennsylvania, Philadelphia, United States |
Cox Automotive | Atlanta, Georgia, United States |
DataMirror | Canada, Markham, Ontario |
Huanqiu Pinhui | Beijing, Beijing, China |
Minghui Jijin | China, Guangdong, Shenzhen |
OpenBox Ventures | New York, New York, United States |
ShangHai MOO Metal Detector Co., Ltd | China, Shanghai |
Stonepeak Infrastructure Partners | New York, New York, United States |
The Barton Partnership | England, London, United Kingdom |
Thieme | Baden-Wurttemberg, Germany, Stuttgart |
Tianfeng Securities | China, Hubei, Wuhan |
Townsend Ventures | Hunt Valley, Maryland, United States |
VvAA | Netherlands, Utrecht, Utrecht |
Wonderland Capital | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Promentis Pharmaceuticals | $2M | 17 Jan 2014 | Milwaukee, Wisconsin, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Promentis Pharmaceuticals | $2M | 17 Jan 2014 | Milwaukee, Wisconsin, United States |